The Inflation Reduction Act (IRA) of 2022 introduced sweeping changes to the US prescription drug market, most notably ...

Drug pricing 2026 forces are reshaping pharmacy economics through Medicare negotiations, FTC actions, and federal pricing models.

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

In the case of brand-name Crestor (rosuvastatin), the average retail price is close to $400 for one month, while a three-month supply at a national pharmacy is $780. For generic rosuvastatin (which ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...

Analysts say TrumpRx, the Trump administration's consumer drug-pricing site, might not deliver lower drug prices for most ...

Joseph Kleiman, president of Buzz Health, discusses the impact of Trump RX on transparency in drug pricing. In his ...

In late 2025, President Donald Trump unveiled a high-profile initiative aimed at tackling one of the most persistent and politically charged issues in American healthcare: sky-high prescription drug ...

A group of six national associations representing food and drug retailers this week urged the passage of a House budget bill that includes efforts to more closely regulate pharmacy benefit management ...

The National Pharmaceutical Pricing Authority has revised retail prices of 28 formulations and capped ceiling prices for six ...